DOCSLIB.ORG

Curriculum Vitae

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Curriculum Vitae 1 CURRICULUM VITAE David Ross Engelke EDUCATION 1974 University of Wisconsin, Madison, B.S. (Biochemistry) 1979 Washington University, St. Louis, Ph.D. (Biological Chemistry) Advisor: Robert G. Roeder POSTDOCTORAL TRAINING 1979-1983 Postdoctoral Fellow, Department of Chemistry, University of California, San Diego, La Jolla, California, Advisor: John Abelson ACADEMIC APPOINTMENTS 1983-1989 Assistant Professor, Department of Biological Chemistry, The University of Michigan, Ann Arbor, Michigan 1989-1996 Associate Professor, Department of Biological Chemistry, The University of Michigan 1996-2015 Professor, Department of Biological Chemistry, University of Michigan 1995 Interim Director, Medical Scientist Training Program 1995-1998 Director, Cellular and Molecular Biology Ph.D. Program, The University of Michigan 1998-2007 Founding Director, Program in Biomedical Sciences, The University of Michigan 2000-2007 Assistant Dean, Graduate and Postdoctoral Studies, UM Medical School 2008-2012 Associate Dean, H. H. Rackham School of Graduate Studies University of Michigan 2009-2010 Founding Director, Michigan Postbaccalaureate Research Education Program (PREP) 2010-2015 Associate Director, Michigan PREP 2013-2015 Chair, Department of Biological Chemistry, University of Michigan 2015-present Professor of Chemistry, University of Colorado Denver | Anschutz Professor of Biochemistry and Molecular Genetics, UC Denver | Anschutz Dean of the Graduate School, UC Denver | Anschutz CONSULTING POSITIONS 1989-1994 Parke-Davis 1990/91 Merck Inc. 1994 NeXstar, Inc. 2000 Parke-Davis 2001 Pfizer 2002 PTC Therapeutics, Incyte, Imgenix, Ambion 2003 Promega, Nucleonics, Pfizer 2004 Benitec, Promega 2004-2005 Benitec Science Advisory Board 2007 Somalogic, Inc. 2010 Allozyne, Inc. 2 SCIENTIFIC ACTIVITIES 1. Grant + Program Review Service Ad hoc reviewer, National Science Foundation 1984-present Member, NIH Molecular Cytology Study Section 1991-95 Representative, NIH Director’s Chairpersons Meeting 1992 Ad hoc member, ACS review panel 1995, 1996 Ad hoc for NIH site visits (2) Member, NIH Biology 2 Study Section 1997-1998 Chair, NIH CDF6 Study Section 1999-2001 Ad hoc for NCI intramural site visit 2002 Ad hoc for NIH CDF2 Study Section 2002 Reviewer, Norwegian Research Council 2003-2010 Reviewer, U. of Miami Biochemistry Dept. Review 2007 Reviewer, U. of Illinois, Chicago, Graduate Programs 2008 Reviewer, U. of Oklahoma Cell Biology Program 2009 Reviewer, Ohio State U. College of Biological Sciences 2009 Ad hoc for NIGMS Genetics ARRA applications 2009 Reviewer, UCLA Biochemistry Dept. and Program 2010 Ad hoc for NIGMS MGB Study Section 2010 Member, NIGMS Special Emphasis study sections (2) 2014 2. Journal Review Associate Editor, RNA (1999-2009) Editorial Board, Nucleic Acids Research (1990-2015) Frequent reviewer for: Biochemistry EMBO J. J. Mol. Biol. Mol. Cell. Biol. J. Biol. Chem. Nucleic Acids Res. Proc. Natl. Acad. Sci. RNA Science Genes & Development Nature Cell Nature Biotech. Molecular Cell Nature Structural and Molecular Biology RECENT EXTRAMURAL INVITED PRESENTATIONS (2002- PRESENT) 2/02 Seminar, Sherbrooke University (Quebec) 3/02 Seminars, Case Western Reserve University (Cleveland) 5/02 Session organizer, International RNA Society Meeting (Madison) 5/02 PTC Therapeutics seminar (New Jersey) 6/02 Incyte Genomics seminar (Newark, Delaware) 6/02 Speaker and session organizer, RNA Polymerases I/III meeting (Asilomar) 8/02 Ambion Inc. seminar (Austin, TX) 10/02 Seminar, University of Notre Dame (South Bend) 11/02 Speaker, “RNA in Drug Development” meeting (San Diego) 12/02 Seminar, City of Hope National Medical Center (Los Angeles) 1/03 Seminar, Nucleonics (Malvern, PA) 1/03 Seminar, Geisinger Clinic (Danville, PA) 1/03 Seminar, Penn State U. Medical School (Hersehy, PA) 2/03 Speaker, “Applications of RNA Interference” conference (San Diego) 2/03 Invited course lecture, Imgenex (San Diego) 3 2/03 Seminar. Stratagene (San Diego) 2/03 Seminar, Michigan State University (East Lansing) 3/03 Speaker and session chair, Gene Functional Analysis Conference (Santa Clara, CA) 4/03 Seminar, U. of South Carolina (Columbia) 6/03 Seminar, Promega (Madison) 6/03 Seminar, Pfizer (Ann Arbor) 9/03 Seminar, Carnegie Mellon University 9/03 Speaker, American Chemical Society meeting, New York 10/03 Speaker, International tRNA Symposium, Banz, Germany 1/04 Seminar, NIH campus 3/04 Seminar, University of Saint Francis 4/04 Seminar, University of Rochester 5/04 Speaker, Benitec session at RNAi meeting, Boston 6/04 Speaker, RNA Polymerase I + III Conference, Asilomar (sent student substitute) 9/04 Speaker, Sherbrooke (Canada) RNA meeting 9/04 Seminar, University of Toledo 10/04 Seminar, Indiana University 11/04 Seminar, Brown University 2/05 Seminar, Ohio State University 4/05 Seminar, Colorado State University (Fort Collins) 5/05 Seminar, U. of Massachusetts (Amherst) 5/05 Seminar, U. of Colorado (Boulder) 8/05 Seminar, Sigma-Aldrich (St. Louis) 10/05 Seminar, Oberlin College 01/06 Seminar, U. of Georgia 05/06 Seminar, U. of Missouri 05/06 Speaker, RNA Polymerase I+III meeting, Asilomar, CA 10/06 Seminar, U. of Arizona 11/06 Seminar, U. of Colorado Health Sciences Center 11/06 Seminar, Michigan State University 5/07 Speaker, Cancer Research UK, London 11/07 Speaker, Michigan Society of Fellows 6/08 Speaker, CIRTL meeting Madison, WI 6/08 Speaker, OddPols meeting, Quebec City, Canada 9/08 Seminar, U. of Oklahoma 9/08 Invited Speaker, Midwest Yeast Meeting, Northwestern U. 10/08 Seminar, Penn State U. 6/09 Speaker, RNA Society meeting, Madison 9/09 Presenter, Nuclear Structure and Dynamics meeting, France 1/10 Seminar, University of Southern California 2/10 Seminar, University of Missouri 6/10 Speaker, RNA Polymerases I + III meeting, Airlie Center, Virginia 7/10 Session chair, World Conference on Research Integrity, Singapore 10/10 Session chair, GREAT group, New Orleans (Program Committee) 11/10 Keynote speaker, MCB Symposium, U. of Iowa 8/11 Seminar, University of Alberta 5/12 Seminar, Stowers Institute (Kansas City) 6/12 Speaker, Session Chair, RNA Pol I+III meeting, Airlie Center, VA 5/13 Speaker, EMBL, Heidelberg 4 10/13 Seminar, National Institutes of Health, Bethesda 6/14 Speaker, Symposium for Anita Hopper 6/14 Organizer, speaker, RNA polymerases I, III, IV + V meeting, Ann Arbor 9/14 Speaker/Session Chair, International tRNA Conference, Kyllini, Greece 5/15 Organizer, Future of Bioscience Graduate and Postdoctoral Training Conference, Ann Arbor, MI 3/16 Speaker, Colorado RNA Club, Boulder 5/16 Organizer, speaker, RNA polymerases I, III, IV + V meeting, Ann Arbor 9/16 Speaker, RiboClub, Sherbrooke, Canada GRANT SUPPORT Ongoing support R25 GM086262-06 (PI: Barald, Engelke is co-I) 12/01/08-09/01/15 0.0 calendar NIH/NIGMS $1,488,602 total costs Michigan Postbaccalaureate Research Education Program This training grant provides up to 10 underrepresented minority recent bachelor’s degree graduates with the opportunity of a 1 year research and preparation for graduate school in the biosciences. Engelke was originally the PI at the time of award, but changed to co-Investigator (and Associate Director) after becoming Associate Dean of the central graduate school in 2009. the first year with permission of NIGMS. OVERLAP: none DGE-1553798 (PI: Engelke) 09/15/15-08/31/20 0.0 calendar NSF $184,000 total costs Graduate Research Fellowship Program The purpose of this grant is to help ensure the vitality and diversity of the scientific and engineering workforce of the United States. The program recognizes and supports outstanding graduate students who are pursuing research-based master’s and doctoral degrees in science and engineering. The GRFP provides three years of support for the graduate education of individuals who have demonstrated their potential for significant achievements in science and engineering. This appointment of Dr. Engelke as the new Dean of the UC Denver/Anschutz Graduate School is pending approval of NSF. OVERLAP: none Completed Support RO1 GM082875-01A1 D. Engelke (PI) 07/01/08-04/30/12 Agency: NIGMS “Nuclear Organization of RNA Polymerase III Transcription” PI: D. Engelke, 25% effort The goal of this proposal is to understand the spatial organization of RNA polymerase III transcription units in eukaryotes and the mechanisms by which these genes are organized. Cayman Chemical contract (Engelke) 05/20/13-05/19/14 Cayman Chemical Company This contract was to create nucleic acid aptamers that recognize specific histone modifications. R25 GM086262 (PI: K. Barald, co-I D. Engelke) 12/01/08-11/30/17 0.0 calendar NIH/NIGMS $341,310 annual direct costs Michigan Postbaccalaureate Research Education Program This training grant provides up to 10 underrepresented minority recent bachelor’s degree graduates with the opportunity of 1 year research and preparation for graduate school in the biosciences. Engelke was originally PI, but stepped down to be co-investigator in 2009 and resigned in 2015 to accept the position in Colorado 5 HRD 1038099 (PI: J. Weiss; co-I D. Engelke) 06/01/11-5/30/16 0.0 calendar National Science Foundation $1,250,000 total costs Building Bridges, Creating Community and Wise Mentoring: Building Institutional Capacity to Enhance Diversity in STEM Disciplines This is an institutional grant to coordinate campus-wide activities in promoting the diversity in the STEM disciplines and optimizing the success of young scientists. I resigned in 2014 since I had changed administrative positions at the University of Michigan HONORS AND AWARDS 1979-1980
Load more

Recommended publications
  • Curriculum Vitae, Nils G. Walter, Dr. Ing. (Chemistry)
    Curriculum Vitae, Nils G. Walter, Dr. Ing. (Chemistry) Department of Chemistry, Rm. 2405 Phone: (734) 615-2060 930 N. University Ave. FAX: (734) 647-4865 University of Michigan E-mail: [email protected] Ann Arbor, MI 48109-1055 http://singlemolecule.lsa.umich.edu http://sites.lsa.umich.edu/walter-lab https://rna.umich.edu PROFESSIONAL EXPERIENCE FACULTY 2020-present Faculty Director of the Microscopy Core in the Biomedical Research Core Facilities (BRCF) 2018 Sabbatical Visitor, Chan Zuckerberg Biohub, San Francisco 2017-present Francis S. Collins Collegiate Professor of Chemistry, Biophysics, and Biological Chemistry, College of Literature, Science and the Arts 2016-present Founding Co-Director, Center for RNA Biomedicine, U. of Michigan; awarded a 5-year $10.2M Biosciences Initiative Award in 2018 to further build this grassroots, 150-faculty member effort 2016-present Professor of Biological Chemistry 2015-present Co-Director, Microfluidics in Biomedical Sciences Training Program 2015-present Associate Director, Michigan Post-baccalaureate Research Education Program (PREP) 2010-present Founding Director, Single Molecule Analysis in Real-Time (SMART) Center 2009-present Professor of Chemistry 2005-2009 Associate Professor of Chemistry 2006 Sabbatical Visitor, Harvard University, with Sunney Xie in Chemistry & Chemical Biology 2006 Distinguished Visitor, JILA, Boulder, with David Nesbitt 2002-2005 Dow Corning Assistant Professor of Chemistry 1999-2005 Assistant Professor of Chemistry 1999-present Member of the Biophysics (since 1999), Applied Physics (since 2000), Cellular & Molecular Biology (since 2001), and Chemical Biology (since 2005) Interdepartmental Graduate Programs University of Michigan, Ann Arbor POSTDOCTORATE 1996-1999 Postdoctoral Research Fellow with Prof. John M. Burke, University of Vermont; Subject: Biophysical Studies of the Hairpin Ribozyme 1995 Postdoctoral Research Fellow with Nobel laureate Prof.
    [Show full text]
  • Interview with Melvin I. Simon
    MELVIN I. SIMON (b. 1937) INTERVIEWED BY SHIRLEY K. COHEN May 24 and June 5, 2005 Melvin I. Simon ARCHIVES CALIFORNIA INSTITUTE OF TECHNOLOGY Pasadena, California Subject area Biology Abstract Interview in two sessions, May 24 and June 5, 2005, with Melvin I. Simon, Anne P. and Benjamin F. Biaggini Professor of Biological Sciences, emeritus, in the Division of Biology. Dr. Simon received his BS from City College of New York in 1959 and his PhD in biochemistry from Brandeis in 1963. After receiving his degree, he was a postdoctoral fellow with Arthur Pardee at Princeton for a year and a half and then joined the faculty of the University of California at San Diego. In 1978, Dr. Simon and his UCSD colleague John Abelson established the Agouron Institute in San Diego, focusing on problems in molecular biology. He (along with Abelson) joined the faculty of Caltech as a full professor in 1982, and he served as chair of the Biology Division from 1995 to 2000. http://resolver.caltech.edu/CaltechOH:OH_Simon_M In this interview, he discusses his education in Manhattan’s Yeshiva High School (where science courses were taught by teachers from the Bronx High School of Science), at CCNY, and as a Brandeis graduate student working working with Helen Van Vunakis on bacteriophage. Recalls his unsatisfactory postdoc experience at Princeton and his delight at arriving at UC San Diego, where molecular biology was just getting started. Discusses his work on bacterial organelles; recalls his and Abelson’s vain efforts to get UCSD to back a full-scale initiative in molecular biology and their subsequent founding of their own institute.
    [Show full text]
  • CURRENT TECHNOLOGY and RESOURCE NEEDS the Specific and Primary Agouronpurposes Are to Perform Research in the Sciences
    The Agouron Institute GEOBIOLOGY CURRENT TECHNOLOGY and RESOURCE NEEDS The specific and primary AGOURONpurposes are to perform research in the sciences INSTITUTEand in mathematics, to disseminate the results obtained therefrom, all to benefit mankind. Cover photo: Phototrophic sulfur and non-sulfur bacteria in an enrichment from a microbial mat reveal part of the enormous diversity of microorganisms. © 2001 The Agouron Institute 45 GEOBIOLOGY CURRENT TECHNOLOGY and RESOURCE NEEDS The Agouron Institute INTRODUCTION 3 GEOBIOLOGY: 5 Current Research General Overview 5 Advances in Probing The Rock Record 6 Advances in Molecular Biology and Genomics 9 Current Research Directions 11 Questions of What and When: Detecting Life in the Geologic Record 12 Molecular Fossils 12 Morphological Fossils 14 Isotopic Signatures 16 Question of Who and How: Deciphering the Mechanisms of Evolution 18 Genetic Diversity 18 Microbial Physiology 20 Eukaryotic Systems 23 Experimental Paleogenetics 25 GEOBIOLOGY: Resource Needs 29 An Intensive Training Course in Geobiology 30 A Postdoctoral Fellowship Program in Geobiology 31 Support for Specific Research Projects 32 REFERENCES 34 2 Agouron Institute had expanded considerably and had obtained additional funding from the NSF and the NIH. A group of molecular biologists and chemists were collaborating to exploit new technology in which synthetic oligonucleotides were used to direct specific mutations in genes. A crystallography group had been INTRODUCTION formed and they were collaborating with the molecular biologists to study the properties of the altered proteins. These were among the very first applications of the new technology to form what is now the very ith the discovery of recombi- large field of protein engineering.
    [Show full text]
  • California Meetings
    California Meetings An artist’s rendering of what the Archean earth looked like at the time of the rise of oxygen. The Birth of Oxygen John Abelson This presentation was given at a meeting of the American Academy, held at the University of California, San Diego, on November 17, 2006. John Abelson is George Beadle Professor of Biology, Emeritus, at the California Institute of Technology, Adjunct Professor of Biochemistry at the University of California, San Francisco, and the President of the Agouron Institute. He has been a Fellow of the American Academy since 1985. We take it for granted that our atmosphere thesis was, after the origin of life itself, the The closely linked evolution of photosyn- contains oxygen, but we and most other ani- most important development in the history thesis and the evolution of the atmosphere is mals would die within minutes if the oxygen of our planet. About twelve times as much perhaps the best example of the interdepen- was removed. It is not widely appreciated energy is derived from the aerobic metabo- dence of biological and geological processes. that for half of the earth’s history there was lism of a molecule of glucose as the energy In chronicling the rise of oxygen, I will ½rst virtually no oxygen in the atmosphere. Oxy- obtained from anaerobic metabolism. With- describe photosynthesis and its origins. Then gen appeared 2.45 billion years ago, and it has out the invention of oxygenic photosynthe- I will turn to a discussion of the state of the been present ever since–though not always sis, multicellular organisms could not have earth and its atmosphere before and during at its present level of 21 percent.
    [Show full text]
  • Identification of Five Putative Yeast RNA Helicase Genes
    Proc. Nati. Acad. Sci. USA Vol. 87, pp. 1571-1575, February 1990 Biochemistry Identification of five putative yeast RNA helicase genes (gene family/degenerate oligonucleotides/polymerase chain reaction) TIEN-HsIEN CHANG, JAIME ARENAS, AND JOHN ABELSON Division of Biology 147-75, California Institute of Technology, Pasadena, CA 91125 Contributed by John Abelson, December 5, 1989 ABSTRACT The RNA helicase gene family encodes a characterized Drosophila gene vasa (7); yeast genes TIFI, group of eight homologous proteins that share regions of TIF2, and MSSJ16 (8, 9); as well as mouse PLIO gene (10). sequence similarity. This group of evolutionarily conserved Based on the amino acid sequence alignments of these pro- proteins presumably all utilize ATP (or some other nucleoside teins, an additional gene family, the RNA helicase gene family, triphosphate)' as an energy source for unwinding double- consisting of both established and putative RNA helicase stranded RNA. Members of this family have been implicated in genes, was defined (11). Although the sequence conservation a variety of physiological functions in organisms ranging from is spread out over a stretch of 420 amino acids, several Escherichia coli to human, such as translation initiation, mito- sequence elements are especially striking. The sequence D X4 chondrial mRNA splicing, ribosomal assembly, and germinal A X4 G K T, found in all eight proteins, is typical for the A line cell differentiation. We have applied polymerase chain motif of ATP binding proteins (12-14). The D E A D reaction technology to search for additional members of the box, (V/I) L D E A D X2 L, on the other hand, represents a RNA helicase family in the yeast Saccharomyces cerevisiae.
    [Show full text]
  • Understanding Pre-Mrna Dynamics in Single Spliceosome Complexes
    Understanding Pre-mRNA Dynamics in Single Spliceosome Complexes by Ramya Krishnan A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Chemistry) in the University of Michigan 2013 Doctoral Committee: Professor Nils G. Walter, Chair Professor Hashim M. Al-Hashimi Professor Carol A. Fierke Assistant Professor Aaron C. Goldstrohm © Ramya Krishnan 2013 To amma, appa, Chikki, Girish and Abhi ii Acknowledgements First, I would like to thank my advisor, Dr. Nils Walter for taking me into his group and giving me the independence to pursue the science I wanted to. My days spent doing experiments have been fun alongside Mario Blanco and Matt Kahlscheuer, whom I have to thank for being great colleagues with a solid team spirit. I am honored to have worked in close collaboration with two great scientists in the field, Drs. John Abelson and Christine Guthrie. I would like to thank them for the insightful and encouraging discussions. For my time spent as a GSI, and for being a source of constant encouragement and support, I want to extend my wholehearted gratitude to Dr. Kathleen Nolta. Finally I would like to thank my friends in the Walter lab for maintaining a congenial environment, full of fun and life. Of course, none of this would be possible without the unconditional love and support from mom, dad and my sister. My mom has always encouraged me to excel in whatever I did, and my dad has set an example for the confident person I am today. I know this will make them proud.
    [Show full text]
  • Nobel Prize Biography
    5/3/2019 Thomas A. Steitz - Biographical This website uses cookies to improve the user experience. By using this website you consent to all cookies in accordance with our cookie policy. I understand Thomas A. Steitz More Thomas A. Steitz Biographical was born in Milwaukee, Wisconsin in 1940, and my family lived in an apartment above a paint store in the downtown I area until 1949. Although my father had obtained a law degree from Marquette University in Milwaukee, he became the administrator in charge of personnel at the Milwaukee County Hospital. My mother grew up on a farm in Waukesha county outside of Milwaukee and graduated from Carol College, a small college in Waukesha. My mother devoted her time to all of the domestic chores required for raising a family which eventually grew to five children – two younger brothers and two younger sisters. My father’s parents lived about 20 blocks away and my mother’s parents and her brother’s family lived on the family farm in Waukesha county. I attended elementary school at the Elm Street School, an old brick building with an asphalt playground located a few blocks from our apartment. I did not like the school much and often got beaten up by a bunch of slightly older guys on my way home from school. My report card, which I brought home for my parents’ signatures at the end of second grade, showed grades that were just above failure. My parents were upset and https://www.nobelprize.org/prizes/chemistry/2009/steitz/biographical/ 1/24 5/3/2019 Thomas A.
    [Show full text]
  • National-Academies-Letter.Pdf
    July 6, 2009 Dear Governor Schwarzenegger: The three hundred signers of this letter write to you as members of the US National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine, and as professors at the University of California to express our deep concern about the latest round of proposed cuts to the UC budget. Current proposals being weighed by your office and the Legislature call for a 19% reduction from 2007-8 levels in state support for UC, producing an $800 million shortfall in the UC budget for the 2009-10 fiscal year. This will lead to increases in student fees, reductions in pay or furloughs for faculty and staff, and cuts in virtually all University services. These cuts will be devastating to every part of the University’s mission, but as scientists and engineers we are particularly concerned about their effects on the future of science and technology in California. While we recognize that our state faces an unprecedented financial crisis, the proposed cuts come on top of a decades-long trend of declining state support for the University of California. The situation has reached a breaking point. Further cuts of the magnitude being contemplated in the latest round of budget proposals are likely to destroy UC’s status as the leading public university in the United States. This would undermine prospects for economic recovery and damage California’s competitiveness for decades. Before making a decision in the heat of a crisis that will have negative consequences for decades to come, we ask that you consider the following: • It is estimated that 85% of per capita economic growth in the United States is due to technological change1, and the University of California has been a leading driver of that change.
    [Show full text]
  • Interview with Seymour Benzer
    SEYMOUR BENZER (1921-2007) INTERVIEWED BY HEIDI ASPATURIAN September 11, 1990–February 1991 Photo by Floyd Clark ARCHIVES CALIFORNIA INSTITUTE OF TECHNOLOGY Pasadena, California Subject area Biology, biophysics Abstract Interview conducted in eleven sessions between September 1990 and February 1991 with Seymour Benzer, James G. Boswell Professor of Neuroscience in the Division of Biology. Benzer received his PhD in physics from Purdue in 1947. His interests had already turned to biophysics, after he read Erwin Schrödinger’s What is Life? In this lengthy interview he recounts his peripatetic life visiting Oak Ridge National Laboratory (1948-49); Max Delbrück at Caltech (1949-51); the Pasteur Institute with André Lwoff, François Jacob, and Jacques Monod (1951-52); the Cavendish Laboratory at Cambridge, with Francis Crick and Sydney Brenner (1957-1958); Roger Sperry’s lab at Caltech (1965-67); and intermittently Woods Hole and Cold Spring Harbor—all while he was also a member first of the physics and then the biology faculty at Purdue (1945-1967). In the early 1960s, he participated for a while in the establishment of the Salk Institute. In 1967 he became a professor of biology at Caltech, meanwhile spending summers in the early 1970s at the Salk Institute; recollections of the Biology Division and of Salk during that time. He discusses the early years and flourishing of molecular biology, including recollections of such pioneers as http://resolver.caltech.edu/CaltechOH:OH_Benzer_S Salvador Luria, Renato Dulbecco, Francis Crick, James Watson, Gunther Stent, and Delbrück’s phage group. He discusses his own work on r mutants of bacteriophage, genetic fine structure, behavioral mutants of Drosophila, and monoclonal antibodies.
    [Show full text]
  • Saccharomyces Cerevisiae JEAN-MICHEL MASSON*T, PIERRE MEURIS**, MICHAEL GRUNSTEIN*, JOHN ABELSON§, and JEFFREY H
    Proc. NatI. Acad. Sci. USA Vol. 84, pp. 6815-6819, October 1987 Genetics Expression of a set of synthetic suppressor tRNAPhe genes in Saccharomyces cerevisiae JEAN-MICHEL MASSON*t, PIERRE MEURIS**, MICHAEL GRUNSTEIN*, JOHN ABELSON§, AND JEFFREY H. MILLER* *Department of Biology and Molecular Biology Institute, University of California, Los Angeles, CA 90024; and §Division of Biology, California Institute of Technology, Pasadena, CA 91125 Contributed by John Abelson, June 15, 1987 ABSTRACT Synthetic ochre and amber tRNA suppressor A OH C genes derived from the yeast tRNAmA sequence have been C constructed. They were efficiently transcribed in vitro and A expressed in vivo via a synthetic expression cassette. tRNAUeA G C and tRNAI AAVS (IVS = intervening sequence) are relatively C G G C inefficient ochre suppressors. They are toxic to the cell when G U expressed on a multicopy plasmid, and they do not suppress at A U all when present as single copies. The intron does not seem to U A have any effect on suppression. In contrast, the amber sup- 2-Me U -A c C U U GACAC A-i-Me pressor tRNAC!AIVS is efficient when expressed from a D ~~~A G single-copy plasmid, while its efficiency is reduced on a D-uU CUCG CUGU UCG multicopy vector. G GAGCGCGGGA G C.GAG 5-Me Suppressor tRNAs are useful genetic tools in investigating C G 5-Me the nature of suppressible mutations as well as the transla- 2-2 diMe- A- U 7-Me tional process. They also provide a very powerful tool for the GO*'U 5-Me analysis of structure-function relationships in proteins by 2'0-Me2'MAUGUCAA allowing defined amino acid substitutions at specified posi- tions.
    [Show full text]
  • John Abelson, Karl Hostetler, Dan Lindsley and John Wheatley Receive John Simon Guggenheim Fellowships
    John Abelson, Karl Hostetler, Dan Lindsley and John Wheatley receive John Simon Guggenheim fellowships April 9, 1980 Four University of California, San Diego faculty members are among 276 scholars, scientists and artists chosen to receive John Simon Guggenheim fellowships for 1980. The winners were chosen from among 3,066 applicants in the foundation's 56th competition. The four UC San Diego Guggenheim Fellows are: Dr. John N. Abelson, professor of chemistry; Dr. Karl Y. Hostetler, associate professor of medicine in residence; Dr. Dan L. Lindsley, professor of biology, and Dr. John C. Wheatley, professor of physics. The fellowships were awarded on the basis of demonstrated accomplishment in the past and strong promise for the future. The winners were selected by an academic committee based on applications and the worthiness of their research proposals. In all, 96 institutions are represented by one or more fellows. Abelson, a member of the UC San Diego faculty for 11 years, is recognized as being a leader in the research of genetic regulation, particularly nucleic acid structure and function. As a Guggenheim Fellow he will continue his studies in this field through a proposal titled, "The Mechanism of Gene Expression in Higher Organisms." Hostetler came to UC San Diego in 1973. His research interests are in phospholipid bile synthesis. He has traveled to Russia to study cancer cells to see if he could find any abnormalities in the way in which the Russians make phospholipids that might account for the differences sometimes found in phospholipids common to cancer cells. Hostetler's research proposal for his Guggenheim Fellowship is titled "Studies in the Biochemistry of Lipids." Lindsley joined the UC San Diego faculty in 1967 and served as chairman of the Department of Biology from 1977 to 1979.
    [Show full text]
  • Voided Matls Licensing Action for License 34-00738-07 for Case
    _______ ___-__ - _ _-_ - _ _ _ _ _ - _ 's ' < a VOID SHEET TO: License Fee Management Branch r 1 FROM: Rlli - _ James MullaueL \ ( SUBJECT: VOIDED APPLICATION Control Number: 303322___ Applicant: Case Western Rese<ve University License Number: 34-00738-07_ Docket Number: 030-07040 {_ 1 Date Voided: 12/18/97 Reason for Void: The licensee's reauest does not require an amendment. A Dhb > > o a L2fl.? 99 ' ' ' / f Signa}ture ( Date Attachment: Official Record Copy of Voided Action l FOR LFMB USE ONLY b Refund Authorized and processed - / \ No Refund Due ; Fee Exempt or Fee Not Required g\g' Comments: Log completed Processed by: . 5 /rd /J k , [i 9712290059 97121s - PDR ADOCK 03007040 f ||;' | h gj C PM - ** * * - I - - _ _ - . - . ,. - 3 (FOR LFM5 USE) INFORMAT!DN FRp'. LTS O BETWEEN: -------------------- i :- License Fee Management Branch, ARM Program Code: 03510 and Status Code: 0 ! --Q Regional Licensing 3ections Fee Cate r: EI 3E Esp. Dat 0011031 : Fee Comments: 170.11(A)(4) Decom Fin Assur Reqdt N O ::::::::::::::::::::::::::::::::::::: LICENSE FEE TRANSMITTAL O A. REC 10N 1. APPLICATION ATTACHED $ Q Applicant / Licensee CASE WESTERN RESERVE UNIVERSITY ' Received Date 971114 '1, Docket No 3007040 -- Control No.: 303322 a License No. 34-00738-07 :: Q Action Types (;m e= 1me nt 2. FEE ATTACHED Amounts Q ,, ,,,, G seck No.: ,,,, __,_, a c~ 3. COMMENTS j ' O si n,, , je- Da e [[[[[h , E f:7 [' '_'',, Q B. LICENSE FEE MANAGEMENT BRANCH (C esh, epsmiWiton is entered /_/),/ * 1. FeeCategoryandAmountsfh _ k L .. ,__,,_______ 2.
    [Show full text]